Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Classifying publications from the clinical and translational science award program along the translational research spectrum: a machine learning approach.

Surkis A, Hogle JA, DiazGranados D, Hunt JD, Mazmanian PE, Connors E, Westaby K, Whipple EC, Adamus T, Mueller M, Aphinyanaphongs Y.

J Transl Med. 2016 Aug 5;14(1):235. doi: 10.1186/s12967-016-0992-8.

2.

Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.

Edwards JP, Datta I, Hunt JD, Stefan K, Ball CG, Dixon E, Grondin SC.

Eur J Cardiothorac Surg. 2016 Jun;49(6):1599-606. doi: 10.1093/ejcts/ezv421. Epub 2016 Jan 21.

PMID:
26796110
3.

Project development teams: a novel mechanism for accelerating translational research.

Sajdyk TJ, Sors TG, Hunt JD, Murray ME, Deford ME, Shekhar A, Denne SC.

Acad Med. 2015 Jan;90(1):40-6. doi: 10.1097/ACM.0000000000000528.

4.

The impact of computed tomographic screening for lung cancer on the thoracic surgery workforce.

Edwards JP, Datta I, Hunt JD, Stefan K, Ball CG, Dixon E, Grondin SC.

Ann Thorac Surg. 2014 Aug;98(2):447-52. doi: 10.1016/j.athoracsur.2014.04.076. Epub 2014 Jun 21.

PMID:
24961839
5.

A novel approach for the accurate prediction of thoracic surgery workforce requirements in Canada.

Edwards JP, Datta I, Hunt JD, Stefan K, Ball CG, Dixon E, Grondin SC.

J Thorac Cardiovasc Surg. 2014 Jul;148(1):7-12. doi: 10.1016/j.jtcvs.2014.03.031. Epub 2014 Mar 26.

6.

Use of social network analysis tools to validate a resources infrastructure for interinstitutional translational research: a case study.

Hunt JD, Whipple EC, McGowan JJ.

J Med Libr Assoc. 2012 Jan;100(1):48-54. doi: 10.3163/1536-5050.100.1.009.

7.

Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants.

Malati CY, Robertson SM, Hunt JD, Chairez C, Alfaro RM, Kovacs JA, Penzak SR.

J Clin Pharmacol. 2012 Jun;52(6):932-9. doi: 10.1177/0091270011407194. Epub 2011 Jun 6.

8.

Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects.

Penzak SR, Robertson SM, Hunt JD, Chairez C, Malati CY, Alfaro RM, Stevenson JM, Kovacs JA.

Pharmacotherapy. 2010 Aug;30(8):797-805. doi: 10.1592/phco.30.8.797.

9.

Theory-Driven Interventions in Psychoneuroimmunology and HIV-1 Infection.

Tyll MD, Goodkin K, Blaney NT, Baldewicz TT, Hunt JD, Asthana D.

CNS Spectr. 2000 May;5(5):25-32.

PMID:
18268465
10.
11.

Abasic sites and survival in resected patients with non-small cell lung cancer.

Zhao H, Shen J, Deininger P, Hunt JD.

Cancer Lett. 2007 Feb 8;246(1-2):47-53. Epub 2006 Mar 6.

PMID:
16519994
12.

TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.

Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Tanière P, Brennan P, Boffetta P, Zaridze DG, Hainaut P.

Cancer Res. 2005 Jun 15;65(12):5076-83.

13.

Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies.

Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P.

Int J Cancer. 2005 Mar 10;114(1):101-8.

14.

Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.

Axelrad TW, Deo DD, Ottino P, Van Kirk J, Bazan NG, Bazan HE, Hunt JD.

FASEB J. 2004 Mar;18(3):568-70. Epub 2004 Jan 8.

PMID:
14715700
16.

Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens.

Hunt JD, Strimas A, Martin JE, Eyer M, Haddican M, Luckett BG, Ruiz B, Axelrad TW, Backes WL, Fontham ET.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1405-12.

18.

Lipid messengers as targets for antiangiogenic therapy.

Robert EG, Hunt JD.

Curr Pharm Des. 2001 Nov;7(16):1615-26. Review.

PMID:
11562302
19.
20.

KRAS mutations are not predictive for progression of preneoplastic gastric lesions.

Hunt JD, Mera R, Strimas A, Gillespie AT, Ruiz B, Correa P, Fontham ET.

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):79-80.

21.

Orthotopic human lung carcinoma xenografts in BALB/c mice immunosuppressed with anti-CD4 monoclonal antibodies and chronic alcohol consumption.

Hunt JD, Robert EG, Zieske AW, Bautista AP, Bukara M, Lei D, Shellito JE, Nelson S, Kolls JK, Skrepnik N.

Cancer. 2000 Jan 15;88(2):468-79.

PMID:
10640982
22.

Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.

Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, Shriver SP.

Pulm Pharmacol Ther. 1999;12(5):291-302.

PMID:
10545285
23.

Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice.

Theodossiou C, Skrepnik N, Robert EG, Prasad C, Axelrad TW, Schapira DV, Hunt JD.

Cancer. 1999 Oct 15;86(8):1596-601.

PMID:
10526291
24.

Cloning and characterization of the prostate-specific membrane antigen promoter.

Good D, Schwarzenberger P, Eastham JA, Rhoads RE, Hunt JD, Collins M, Batzer M, Theodossiou C, Kolls JK, Grimes SR.

J Cell Biochem. 1999 Sep 1;74(3):395-405.

PMID:
10412041
25.

KRAS mutations predict progression of preneoplastic gastric lesions.

Gong C, Mera R, Bravo JC, Ruiz B, Diaz-Escamilla R, Fontham ET, Correa P, Hunt JD.

Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):167-71.

26.

Recombinant oncotoxin AR209 (anti-P185erbB-2) diminishes human prostate carcinoma xenografts.

Skrepnik N, Zieske AW, Bravo JC, Gillespie AT, Hunt JD.

J Urol. 1999 Mar;161(3):984-9.

PMID:
10022738
27.

Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers.

Shriver SP, Shriver MD, Tirpak DL, Bloch LM, Hunt JD, Ferrell RE, Siegfried JM.

Mutat Res. 1998 Nov;406(1):9-23.

PMID:
9920051
28.

Aggressive administration of recombinant oncotoxin AR209 (anti-ErbB-2) in athymic nude mice implanted with orthotopic human non-small cell lung tumours.

Skrepnik N, Zieske AW, Robert E, Bravo JC, Mera R, Hunt JD.

Eur J Cancer. 1998 Sep;34(10):1628-33.

PMID:
9893641
29.

The mouse deafness locus (dn) is associated with an inversion on chromosome 19.

Viñas AM, Drury SS, DeAngelis MM, Den Z, Huang JM, Berlin CI, Hunt JD, Batzer MA, Deininger PL, Keats BJ.

Biochim Biophys Acta. 1998 Sep 30;1407(3):257-62.

30.

Detection of K-ras mutations in resected primary leiomyosarcoma.

Hill MA, Gong C, Casey TJ, Menon AG, Mera R, Gillespie AT, Giardina JF, Levine EA, Hunt JD.

Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1095-100.

31.

Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics.

Schwarzenberger P, Hunt JD, Robert E, Theodossiou C, Kolls JK.

J Virol. 1997 Nov;71(11):8563-71.

32.

Prognostic value of specific KRAS mutations in lung adenocarcinomas.

Siegfried JM, Gillespie AT, Mera R, Casey TJ, Keohavong P, Testa JR, Hunt JD.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):841-7.

33.

Percutaneous implantation of non-small-cell lung carcinoma: technique and observations.

Hamide JP, Qian Z, Xu H, Diethelm L, Skrepnik N, Castaneda-Zuniga WR, Hunt JD.

Acad Radiol. 1997 Sep;4(9):629-33.

PMID:
9288190
34.

Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.

Siegfried JM, DeMichele MA, Hunt JD, Davis AG, Vohra KP, Pilewski JM.

Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):358-66.

PMID:
9279210
35.

Tumor specific Epstein-Barr virus infection is not associated with leiomyosarcoma in human immunodeficiency virus negative individuals.

Hill MA, Araya JC, Eckert MW, Gillespie AT, Hunt JD, Levine EA.

Cancer. 1997 Jul 15;80(2):204-10.

PMID:
9217031
36.

Effects of anti-erbB-2 (HER-2/neu) recombinant oncotoxin AR209 on human non-small cell lung carcinoma grown orthotopically in athymic nude mice.

Skrepnik N, Araya JC, Qian Z, Xu H, Hamide J, Mera R, Hunt JD.

Clin Cancer Res. 1996 Nov;2(11):1851-7.

37.

Evaluation of phenotypic alteration by microcell-mediated chromosome transfer.

Hunt JD.

Anal Biochem. 1996 Jul 1;238(2):107-16. Review. No abstract available.

PMID:
8660599
38.

Manipulation of the helper T cell response to influence antigenic competition occurring with a multivalent vaccine.

Hunt JD, Brown LE, Wood PR, Stewart DJ, Jackson DC.

Immunol Cell Biol. 1996 Feb;74(1):81-9.

PMID:
8934658
39.

Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification.

Kasprzyk PG, Sullivan TL, Hunt JD, Gubish CT, Scoppa CA, Oelkuct M, Bird R, Fischer PH, Siegfried JM, King CR.

Clin Cancer Res. 1996 Jan;2(1):75-80.

40.

Immunological parameters associated with antigenic competition in a multivalent footrot vaccine.

Hunt JD, Jackson DC, Wood PR, Stewart DJ, Brown LE.

Vaccine. 1995 Dec;13(17):1649-57.

PMID:
8719515
41.

Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval.

Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou JY, Taguchi T, Keller SM.

Genes Chromosomes Cancer. 1994 Nov;11(3):178-94.

PMID:
7530487
42.

Ability to culture resectable non-small cell lung carcinomas is correlated with recurrence.

Siegfried JM, Davis AL, Testa JR, Hunt JD, Keenan RJ, Yousem SA, Ritter PS, Ferson PF, Landreneau RJ.

Ann Thorac Surg. 1994 Sep;58(3):662-6; discussion 667.

PMID:
7944686
43.

Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells.

DeMichele MA, Davis AL, Hunt JD, Landreneau RJ, Siegfried JM.

Am J Respir Cell Mol Biol. 1994 Jul;11(1):66-74.

PMID:
8018339
44.

Antigenic competition in a multivalent foot rot vaccine.

Hunt JD, Jackson DC, Brown LE, Wood PR, Stewart DJ.

Vaccine. 1994 Apr;12(5):457-64.

PMID:
7912871
45.

Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions.

Siegfried JM, Han YH, DeMichele MA, Hunt JD, Gaither AL, Cuttitta F.

J Biol Chem. 1994 Mar 18;269(11):8596-603.

46.

Transfer and expression of the human interleukin-4 gene in carcinoma and stromal cell lines derived from lung cancer patients.

Hunt JD, Pippin BA, Landreneau RJ, Jacob WF, Lotze MT, Siegfried JM.

J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):314-21.

PMID:
8280714
47.

Cytogenetic abnormalities in non-small cell lung carcinoma: similarity of findings in conventional and feeder cell layer cultures.

Siegfried JM, Hunt JD, Zhou JY, Keller SM, Testa JR.

Genes Chromosomes Cancer. 1993 Jan;6(1):30-8.

PMID:
7680219
48.

Transforming growth factor-alpha gene expression in late-gestation fetal rat lung.

Kubiak J, Mitra MM, Steve AR, Hunt JD, Davies P, Pitt BR.

Pediatr Res. 1992 Mar;31(3):286-90.

PMID:
1561017
49.

Molecular evaluation of abnormalities of the short arm of chromosome 1 in neuroblastoma.

Hunt JD, Tereba A.

Genes Chromosomes Cancer. 1990 Jul;2(2):137-46.

PMID:
1980608
50.

Supplemental Content

Support Center